Skip to Content

NovoSeven RT (coagulation factor viia) Disease Interactions

There is 1 disease interaction with NovoSeven RT (coagulation factor viia):

Major

Coagulation factor VIIa (Includes NovoSeven RT) ↔ thrombosis

Severe Potential Hazard, Moderate plausibility. Applies to: Thrombotic/Thromboembolic Disorder

Serious arterial and venous thrombotic events have been reported with the use of coagulation factor VIIa. Patients at an increased risk of thromboembolic complications may include those with a history of coronary heart disease, liver disease, disseminated intravascular coagulation, post-operative immobilizations, elderly patients, and neonates. It is recommended to exercise caution when administering coagulation factor VIIa to patients at risk and the potential benefit of treatment should be weighed against the risk of these complications.

NovoSeven RT (coagulation factor viia) drug interactions

There are 5 drug interactions with NovoSeven RT (coagulation factor viia)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide